SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001504167-17-000009
Filing Date
2017-03-23
Accepted
2017-03-23 16:12:29
Documents
3
Period of Report
2017-03-23
Items
Item 2.02: Results of Operations and Financial Condition

Document Format Files

Seq Description Document Type Size
1 8-K bpmx-20170323x8k.htm 8-K 39040
2 EX-99.1 bpmx-20170323ex991712a5d.htm EX-99.1 310936
3 GRAPHIC bpmx20170323ex991712a5d001.jpg GRAPHIC 7098
  Complete submission text file 0001504167-17-000009.txt   360895
Mailing Address 1505 ADAMS DRIVE, SUITE D MENLO PARK CA 94025
Business Address 1505 ADAMS DRIVE, SUITE D MENLO PARK CA 94025 650-889-5020
BioPharmX Corp (Filer) CIK: 0001504167 (see all company filings)

IRS No.: 593843182 | State of Incorp.: DE | Fiscal Year End: 0131
Type: 8-K | Act: 34 | File No.: 001-37411 | Film No.: 17709880
SIC: 2834 Pharmaceutical Preparations